CLASS II Drug recall · Reported 29 Jun 2022 · FDA Enforcement Report

Tretinoin Capsules, 10 mg recalled by Teva Pharmaceuticals USA

Teva Pharmaceuticals USA is recalling Tretinoin Capsules, 10 mg, distributed nationwide in the US. The recall was initiated on 14 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: 100022971, Exp. 08/2022; 100022972, Exp. 05/2023; 100028920, Exp. 09/2023
Quantity recalled4941 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1156-2022
FDA event ID
90430
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Classification
Class II
Status
Terminated
Recall initiated
14 Jun 2022
FDA classified
23 Jun 2022
Reported
29 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

14 Jun 2022Recall initiated by company
23 Jun 2022Classified by FDA+9 days
29 Jun 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.

Where it was distributed

Nationwide in the U.S.

Nationwide

Questions about this recall

Is Tretinoin Capsules, 10 mg recalled?

Yes. Teva Pharmaceuticals USA recalled Tretinoin Capsules, 10 mg on 14 Jun 2022. The recall is Class II and its status is Terminated. Recall number D-1156-2022.

Why was it recalled?

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Which lots are affected?

Lot #s: 100022971, Exp. 08/2022; 100022972, Exp. 05/2023; 100028920, Exp. 09/2023

Where was it sold?

Nationwide in the U.S.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 84

Other Tretinoin recalls

All 4